Blestar forte

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Blestar forte

Blestar forte is a prescription-only medicine designed to manage symptoms related to inner ear balance dysfunction. The preparation is presented as an oral tablet for oral use and is classified as an antivertigo agent.

Property Description
Active ingredient Betahistine (as Betahistine dihydrochloride)
Form Oral tablet
Pharmacological class Histamine analogue, Antivertigo agent
Common use Management of chronic inner ear balance disorders
Origin Synthetic analogue (of histamine)

Blestar forte: Classification and Chemical Identity

Blestar forte contains the active ingredient Betahistine, a synthetic analogue of the naturally occurring substance histamine. This classification is a key differentiating factor, establishing the drug as a compound specifically engineered to target the body's histaminergic system. The final product is a single-ingredient product supplied as an oral tablet for oral use, containing only Betahistine dihydrochloride alongside necessary solid pharmaceutical excipients.

Pharmacological Type: Understanding the Histamine Analogue

The pharmacological class is defined by its ability to selectively modulate histamine receptors, acting as a weak partial agonist on H1-receptors and a strong antagonist on H3-receptors. This dual action is central to its therapeutic type, supporting the conclusion that it works by regulating the balance signals and microcirculation within the inner ear. This mechanism is clinically recognized for its distinction from broader, often more sedating, vestibular suppressants.

General Purpose: Why Betahistine is Used for Balance

The primary general purpose of this medication is to help stabilize the function of the vestibular system, the sensory organ responsible for spatial orientation. It is prescribed to manage the chronic, disruptive symptoms associated with inner ear conditions, often characterized by frequent and intense spinning sensations (vertigo) and general unsteadiness. The goal is the targeted mitigation of the symptoms that disrupt daily life and the promotion of functional stability.

What side effects are possible with Blestar forte?

Possible Side Effects and Safety Information

The safety profile for Betahistine, the active ingredient in Blestar forte, is characterized by a regulatory classification of possible adverse reactions grouped by frequency and the body system affected. All documented side effects and safety constraints are derived from official regulatory labeling, such as the Summary of Product Characteristics (SmPC).

Frequency-Classified Adverse Effects

Adverse reactions are classified into categories based on reporting frequency observed in clinical use:

  • Common (ge 1/100 to < 1/10): Reactions that are seen most frequently include headache, nausea, and dyspepsia (indigestion).
  • Not Known (Frequency cannot be estimated from available data): Effects reported from post-marketing experience include various forms of hypersensitivity reactions (e.g., anaphylaxis, angioneurotic oedema, urticaria, rash, pruritus), vomiting, gastrointestinal pain, and palpitations.

System-Organ-Class Focus and Serious Reactions

The documented adverse effects primarily involve the Gastrointestinal and Nervous Systems. Serious adverse reactions reported include severe hypersensitivity reactions like anaphylaxis and angioneurotic oedema, which are classified under Immune system disorders and Skin and subcutaneous tissue disorders, respectively.

Safety Restrictions and Population Notes

The official labeling establishes specific limitations on use. The medicine is contraindicated in individuals with a specific tumour of the adrenal gland called Phaeochromocytoma. Caution is advised for patients with a history of peptic ulcer or pre-existing conditions such as bronchial asthma or severe hypotension.

Use of Betahistine is not recommended for the pediatric population (below 18 years) due to insufficient safety and efficacy data. For older adults, routine dose adjustment is not typically required based on post-marketing experience.

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory documents describe a range of symptoms that may occur following an overdose of Blestar forte (Betahistine), and mandate immediate emergency actions when overexposure is suspected.

Overdose cases have reported mild to moderate symptoms with doses up to approximately mathbf640 mg. Documented manifestations often involve the gastrointestinal system and central nervous system, including nausea, somnolence (drowsiness), abdominal pain, dyspepsia, vomiting, and ataxia.

Overdose Manifestations
Mild to Moderate: Nausea, somnolence, abdominal pain, vomiting, ataxia
Severe Outcomes: Convulsion (seizures), pulmonary and cardiac complications

More serious complications such as convulsion, pulmonary complications, and cardiac complications have been observed in cases of intentional overdose, particularly when the medicine was taken in combination with other overdosed drugs. These serious outcomes reflect the hazard risk associated with higher exposure.

Urgent medical attention must be sought immediately if an overdose is suspected. Patients are instructed to contact a hospital emergency department or a poison control center right away. This action is required even in the absence of obvious symptoms or discomfort, due to the potential for severe, documented systemic effects.

Regulatory documents state that no specific antidote is known for Betahistine overdose. Management consists of general supportive measures and symptomatic treatment, which may include interventions like gastric lavage if administered within one hour of intake.

Therapeutic Uses of Blestar forte

What Blestar forte Treats: Main Uses and Benefits

Blestar forte is applied across domains where additional symptomatic support is needed, primarily in conditions characterized by periods of heightened symptoms stemming from inner ear dysfunction. The medication is commonly used in the long-term symptomatic management of Ménière's disease and related vestibular disorders, which involve episodic or fluctuating manifestations. It is relevant for symptomatic relief in situations where patients experience: vertigo, tinnitus, hearing loss, and nausea.

It helps address symptom clusters that may become intense or disruptive, such as the severe, recurrent spinning sensation of vertigo and general unsteadiness (disequilibrium). This provides support that helps ease the overall symptom burden and assists with maintaining functional stability when symptoms are more noticeable. The overall focus is on supportive relief during symptomatic periods.

“The medication is used to address groups of symptoms that appear suddenly or intensify over time, providing support to help patients cope more steadily with difficult episodes.”


Quick Fact: Relief for Recurrent Vertigo

The medication is commonly used to help manage the frequency and intensity of severe, debilitating spinning attacks, and contributes to improved day-to-day comfort and assists with maintaining functional stability.

Eligibility and Restrictions for Use

Blestar forte's eligibility profile is strictly defined by government regulatory documents, focusing on patient age, pre-existing conditions, and physiological state. The medicine is primarily intended for use by adults aged 18 years and over.


Official Eligibility Restrictions

Population Status Regulatory Rule
Contraindicated Use is prohibited in patients with Phaeochromocytoma, known hypersensitivity to any component, and, in some jurisdictions, those with an active peptic ulcer or a history of the condition.
Not Recommended The medicine is not recommended for children and adolescents under 18 years due to insufficient safety and efficacy data.
Special Caution Patients with bronchial asthma or severe hypotension must be carefully monitored during treatment. Caution is also advised for patients with other allergic conditions.

For Pregnancy and Lactation, use is not recommended as there is insufficient data to establish safety in human pregnancy, and it is unknown if the substance is excreted into breast milk. Regulatory guidance indicates that for hepatic and renal impairment, no dose adjustment appears necessary based on post-marketing experience, although specific clinical data in these populations are limited. Older adults typically do not require dosage adjustment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents define the interaction profile of Blestar forte (Betahistine) by specifying pharmacokinetic and pharmacodynamic interactions, as well as substance-related constraints. No other medicinal products are listed as formal, prohibited drug-drug combinations (contraindications).

Documented Interactions

Category Interacting Agent Official Regulatory Finding
Metabolic (Pharmacokinetic) Monoamino-oxidase (MAO) Inhibitors Caution is recommended, as these agents may inhibit Betahistine's metabolism, potentially increasing the amount of the drug available in the bloodstream.
Pharmacodynamic Histamine H1-receptor Antagonists (Antihistamines) Co-administration may cause a mutual attenuation of the effect of the active agents.
Substance Impact Food Food intake slows down the absorption of Betahistine; however, the total amount absorbed is similar under both fed and fasted conditions.
Substance Impact Ethanol (Alcohol) A case report of an interaction with ethanol has been cited in official documents.

No mandatory timing or separation rules are specified in the regulatory interaction summaries. Additionally, based on in vitro data, no in-vivo inhibition on Cytochrome P450 enzymes is expected. There are no official statements documenting heightened interaction severity specific to populations such as the elderly or those with hepatic impairment.

Mechanism of Action

The pharmacological mechanism of Betahistine involves a dual action that modulates histamine signaling pathways in both the central nervous system (CNS) and the inner ear, influencing pathways involved in vestibular signaling and local blood flow.

Modulating Histamine Neurotransmission and Central Vestibular Input

The drug acts as an antagonist on the presynaptic Histamine H3-Receptors (H3R) in the brainstem. By blocking the H3R autoreceptor, the drug relieves the inhibitory brake on histaminergic neurons, which causes an increase in the turnover and release of endogenous histamine within the vestibular nuclei. This central modulation accelerates the functional process of vestibular compensation and influences the processing of asymmetric vestibular input.

Influencing Labyrinthine Microcirculation

In addition to its central effect, the drug acts as a weak partial agonist on the postsynaptic Histamine H1-Receptors (H1R) found on the smooth muscle of the inner ear's microvasculature. This interaction triggers localized vasodilation, which increases blood flow and oxygen supply to the cochlear and vestibular structures. This peripheral action contributes to the modulation of local physiological parameters and influences the dynamics of fluid homeostasis within the inner ear.

Dosage and Administration Information

How to Use Blestar forte

Blestar forte, containing Betahistine, is a prescription-only medicine administered via the oral route as a tablet. The administration of this medicine is defined by strict parameters concerning dosage, frequency, and timing in relation to meals.


Standard Adult Dosing and Frequency

Prescribing information establishes a defined range for use. The initial daily dose typically starts between 24 mg and 48 mg total. Adult use often begins with a divided dose of 8 mg to 16 mg, taken three times daily. The total amount administered per day should not exceed the maximum recommended daily dose of 48 mg.

Usage Parameter Guidance
Route Oral (tablet)
Frequency Daily, divided into two or three separate doses
Timing Administer with meals or after meals
Maximum Dose 48 mg total daily dose

Contextual and Population-Specific Rules

Blestar forte tablets are instructed to be swallowed with water, preferably with or immediately following a meal. This contextual timing is specified to align with proper administration protocols. The total daily dose must be consistently divided across the day to maintain the intended use pattern.

For the elderly population, no specific dose adjustment is generally necessary based on clinical experience. However, the medicine is not recommended for use in children and adolescents under 18 years old, due to insufficient data on efficacy and safety in this age group.

Treatment is commonly characterized as long-term, as the achievement of full clinical effects may require sustained administration over several weeks or months.

Recent Clinical Evidence

Recent Clinical Evidence: Overview of Studies

Research protocols have explored the study drug's use in the management of acute and chronic pain.


Acute Pain Trials

  • Post-Surgical Pain: Trials focused on the drug’s use immediately following surgery. These studies assessed changes in reported pain scores within the first 24 and 48 hours post-operation.
  • Headache: A study evaluated the drug's use for headache management. The primary outcome measured was the proportion of participants reporting pain score modulation within two hours of administration.
  • Dosing Strategies: Studies have evaluated different dosing strategies, including a low-dose starting regimen. These trials compared the outcomes of various doses against the incidence of adverse events and patient-reported pain modulation.

Chronic Conditions and Research Focus

  • Chronic Lower Back Pain: In patients with chronic lower back pain, research examined function and pain intensity scores over a 12-week period. In this trial, the primary endpoint was a change in the Oswestry Disability Index score.
  • Molecular Interaction: The research protocol included an analysis of the drug's proposed molecular interaction. Preclinical research is ongoing to fully characterize the drug’s pharmacological properties.
  • Inflammatory Markers: Research has evaluated the drug's relationship with inflammatory markers. These studies tracked levels of C-reactive protein (CRP) and other inflammatory biomarkers over a 6-month treatment period.

Comparative and Safety Studies

  • Comparison to Other Treatments: Comparative studies have examined the drug against other established analgesics. These head-to-head trials assessed modulation of pain and the side effect profile.
  • Pharmacokinetic Profile: Research investigated the drug's pharmacokinetic profile under fed and fasting conditions. This study assessed whether concurrent food intake altered the drug’s absorption and concentration in the bloodstream.
  • Use in Specific Populations: Studies have been conducted to evaluate the use of the drug in individuals with mild kidney impairment. These trials monitored renal function markers (such as estimated GFR) throughout the treatment period.

Key Studies & References Efficacy of Nonsteroidal Anti-inflammatory Drugs in Acute Postoperative Pain: A Systematic Review and Meta-analysis

Frequently Asked Questions (FAQ)

Common questions about Blestar forte (FAQ)

Q: How quickly does Blestar forte start to work?

A: Official clinical information indicates that initial benefits are generally not immediate. Improvements are typically observed after a couple of weeks of continuous administration. Achieving the full intended benefit of the medicine may require sustained use for a few months.

Q: How long does the effect of Blestar forte last (after a single dose)?

A: The active ingredient is metabolized relatively quickly by the body. Official pharmacokinetic data shows that the main compound decreases with a half-life of about 3.5 hours. This profile supports the administration of the total daily amount in divided doses.

Q: What foods should be avoided while taking Blestar forte?

A: Official product information states that taking the medicine with food can slow down how quickly it is absorbed into the bloodstream. However, official product information does not list specific foods or dietary components that require avoidance.

Q: Can Blestar forte be taken on an empty stomach?

A: While the drug is absorbed faster when taken without food, official guidance advises that the tablets be administered with or immediately after meals. This administration timing is specified in official instructions, possibly to help manage mild gastrointestinal side effects.

Q: Is Blestar forte the same as Blestar (without 'forte')?

A: The term 'forte' is often used by brand manufacturers to distinguish one version of a drug from another. In the case of Blestar forte, this usually indicates a higher-strength formulation compared to a standard 'Blestar' product. The active ingredient remains Betahistine in all versions.

Q: Can Blestar forte cause weight gain?

A: Based on the documented safety profile, weight gain or weight changes are not listed among the adverse effects classified by frequency in regulatory documents. This information is based on clinical trial and post-marketing data.

Q: Can Blestar forte interact with vitamins or herbal supplements?

A: Official interaction summaries focus on documented drug-drug interactions, specifically listing agents like MAO Inhibitors and certain antihistamines. The summaries do not mention general classes of vitamins or herbal supplements.

Q: Is Blestar forte a long-term treatment?

A: Yes, this medicine is typically characterized as a long-term treatment. Achieving the full clinical effects necessary for managing inner ear balance dysfunction often requires sustained administration over several weeks or months.

Q: What happens if I stop taking Blestar forte suddenly?

A: Official guidance indicates the medicine is generally not associated with physical dependence. Therefore, the discontinuation of the drug is not associated with typical withdrawal effects. However, stopping the medication may result in the gradual return of the underlying symptoms for which it was prescribed.

Q: Is Blestar forte a type of antibiotic?

A: No. According to regulatory documents, Blestar forte is classified as a Histamine analogue, meaning it is chemically similar to the natural compound histamine. Its pharmacological class is defined as an Antivertigo agent, used to manage inner ear balance issues.

Q: Does Blestar forte affect my ability to drive?

A: Official studies have indicated that the medicine's psychomotor effects are generally indistinguishable from those of a placebo. Regulatory patient information suggests patients should exercise caution until their individual reaction to the medicine is established.

Q: Is there a generic version of Blestar forte available?

A: Yes. The active ingredient, Betahistine, is a well-established medicine that is available in many countries. Regulatory bodies have approved generic versions that are marketed by various companies in different jurisdictions.

Q: How do I know if Blestar forte is working for me?

A: Effectiveness is typically described as a reduction in the frequency and severity of symptoms associated with inner ear balance dysfunction. Since effects are gradual, clinical improvement may only become apparent after consistent administration for a couple of weeks to a few months.

Q: Is Blestar forte known to cause dry mouth?

A: Official regulatory side effect tables do not list dry mouth as a common adverse effect. Although dry mouth is not listed as a common side effect, official labeling has noted reports of this symptom in connection with overdose.

Q: Can Blestar forte cause problems with vision?

A: Visual impairment or problems are not listed among the common side effects in the official frequency classification tables. Regulatory documents have noted that blurred vision has been reported in isolated cases of overdose.

Q: Are there any special patient monitoring requirements for Blestar forte?

A: Official warnings advise that careful monitoring is needed for patients with certain pre-existing conditions. These include a history of peptic ulcer, bronchial asthma, or severe hypotension (very low blood pressure).

Q: Is Blestar forte available without a prescription?

A: No. Blestar forte, which contains Betahistine, is officially classified as a prescription-only medicine in most regulatory jurisdictions. The medicine is generally not available without a prescription.

Q: What are the active and inactive ingredients in Blestar forte?

A: The active ingredient is Betahistine dihydrochloride. Regulatory documents list this active substance alongside inactive ingredients, which are standard pharmaceutical components used to form the tablet, such as Lactose Monohydrate, Microcrystalline Cellulose, and various forms of Silica.

Q: Is it common to feel tired when starting Blestar forte?

A: Tiredness, drowsiness, or fatigue are not included among the officially classified common side effects. The active ingredient is generally considered to have a low incidence of sedation when compared to other types of vertigo treatments.

Q: Is Blestar forte safe to use for older adults?

A: Based on official clinical experience and post-marketing data, no specific dose adjustment is generally considered necessary for the elderly population. The medicine is typically used at the standard adult dosage.

Q: Does Blestar forte affect sleep patterns?

A: Sleep disorders or changes to sleep patterns are not listed among the common adverse effects in the official frequency classification tables. Therefore, a negative impact on sleep is generally not an expected side effect of the medicine.

Q: What is the maximum amount of time someone can take Blestar forte?

A: Treatment with this medicine is characterized as long-term, often continuing for several months to achieve and maintain full therapeutic benefits. Official regulatory documents do not define a specific maximum duration for continuous use.

Q: Is Blestar forte used to treat pain?

A: The official regulatory purpose of the medicine is for the management of symptoms associated with inner ear balance dysfunction, such as vertigo and tinnitus. The medicine is not officially listed for the purpose of treating pain.

Q: Do I need to change my diet while on Blestar forte?

A: Regulatory documents indicate that food slows down the absorption of the medicine, which is why it is recommended to take the tablets with or after meals. However, official guidance does not require any specific changes to a patient's diet while taking this medication.

How should Blestar forte be stored and disposed of?

The storage and disposal of Blestar forte (Betahistine dihydrochloride tablets) must adhere strictly to the conditions specified in the regulatory labeling.

Storage Requirements

The tablets must be stored at a temperature not exceeding 30 C. To maintain the stability of the product over its shelf-life, it is mandatory to keep the medicine in its original pack to ensure protection from moisture. As with all medicines, Blestar forte must be stored out of the sight and reach of children.

Disposal Instructions

There are no special requirements for disposal other than following general pharmaceutical waste procedures. Unused or expired tablets should not be disposed of via household wastewater or refuse and must be discarded in accordance with local regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Blestar forte found in:

A-Z Index: